Reports for TEVA CANADA LIMITED
Formerly known as ACTAVIS PHARMA COMPANY
Company Name
TEVA CANADA LIMITED
Shortage reports
Actual shortage:
285 (9%)
Anticipated shortage:
1 (0%)
Avoided shortage:
10 (0%)
Resolved:
3009 (91%)
3305
Discontinuation Reports
To be discontinued:
2 (0%)
Discontinued:
411 (94%)
Reversed:
23 (5%)
436
485 (13%)
23 (8%)
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| ACT CELECOXIB | 100MG | CAPSULE | Resolved | 2017-03-17 | 2018-10-11 | 3390 |
| ACT CELECOXIB | 200MG | CAPSULE | Resolved | 2018-12-04 | 2019-08-06 | 68586 |
| ACT CELECOXIB | 100MG | CAPSULE | Resolved | 2021-01-22 | 2021-02-12 | 132297 |
| ACT CIPROFLOXACIN | 500MG | TABLET | Actual shortage | 2025-11-13 | 2026-03-17 | 271785 |
| ACT CIPROFLOXACIN | 500MG | TABLET | Resolved | 2020-04-02 | 2020-05-21 | 110643 |
| ACT CIPROFLOXACIN | 500MG | TABLET | Resolved | 2019-09-12 | 2019-10-10 | 93644 |
| ACT CIPROFLOXACIN | 250MG | TABLET | Resolved | 2020-05-08 | 2020-05-21 | 114436 |
| ACT CIPROFLOXACIN | 750MG | TABLET | Resolved | 2022-10-28 | 2023-06-09 | 173040 |
| ACT CIPROFLOXACIN | 750MG | TABLET | Resolved | 2018-09-12 | 2018-10-11 | 61365 |
| ACT CIPROFLOXACIN | 750MG | TABLET | Actual shortage | 2025-11-27 | 2026-03-17 | 272748 |
| ACT CIPROFLOXACIN | 750MG | TABLET | Resolved | 2021-11-25 | 2022-02-05 | 149934 |
| ACT CIPROFLOXACIN | 500MG | TABLET | Resolved | 2018-12-04 | 2019-03-12 | 68599 |
| ACT CIPROFLOXACIN | 250MG | TABLET | Resolved | 2021-11-25 | 2023-10-05 | 149931 |
| ACT CIPROFLOXACIN | 750MG | TABLET | Resolved | 2020-04-02 | 2020-09-03 | 110646 |
| ACT CIPROFLOXACIN | 250MG | TABLET | Resolved | 2023-06-19 | 2023-07-05 | 195585 |
| ACT CIPROFLOXACIN | 500MG | TABLET | Resolved | 2021-02-05 | 2023-06-09 | 133460 |
| ACT CIPROFLOXACIN | 500MG | TABLET | Resolved | 2019-06-18 | 2019-07-15 | 86923 |
| ACT CLARITHROMYCIN XL | 500MG | TABLET (EXTENDED-RELEASE) | Resolved | 2020-07-09 | 2023-04-28 | 119901 |
| ACT CLARITHROMYCIN XL | 500MG | TABLET (EXTENDED-RELEASE) | Resolved | 2020-01-09 | 2020-05-29 | 102945 |
| ACT CLARITHROMYCIN XL | 500MG | TABLET (EXTENDED-RELEASE) | Resolved | 2024-01-11 | 2024-05-16 | 215737 |
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| ACT ENALAPRIL | 8MG | TABLET | Discontinued | 2025-05-28 | 2025-05-28 | 258676 |
| ACT ENALAPRIL | 4MG | TABLET | Discontinued | 2025-05-28 | 2025-05-28 | 258682 |
| ACT ESCITALOPRAM | Discontinued | 2018-10-17 | 2018-10-17 | 64535 | ||
| ACT ESCITALOPRAM | Discontinued | 2018-10-17 | 2018-10-17 | 64532 | ||
| ACT ESCITALOPRAM | Discontinued | 2018-10-17 | 2018-10-17 | 64529 | ||
| ACT ESCITALOPRAM | Discontinued | 2018-10-17 | 2018-10-17 | 64526 | ||
| ACT ESCITALOPRAM | Discontinued | 2018-10-17 | 2018-10-17 | 64520 | ||
| ACT ETIDROCAL | 400MG 500MG | TABLET | Discontinued | 2019-02-21 | 2019-03-01 | 76486 |
| ACT FLUCONAZOLE | 100MG | TABLET | Discontinued | 2025-05-28 | 2025-05-28 | 258703 |
| ACT FLUCONAZOLE | 50MG | TABLET | Discontinued | 2025-05-28 | 2025-05-28 | 258697 |
| ACT LEVETIRACETAM | 500MG | TABLET | Discontinued | 2020-01-24 | 2020-01-24 | 104304 |
| ACT LEVOFLOXACIN | 500MG | TABLET | Discontinued | 2025-09-02 | 2025-09-02 | 266380 |
| ACT LEVOFLOXACIN | 250MG | TABLET | Discontinued | 2025-09-02 | 2025-09-02 | 266377 |
| ACT LEVOFLOXACIN | 750MG | TABLET | Discontinued | 2025-09-02 | 2025-09-02 | 266383 |
| ACT NABILONE | 1MG | CAPSULE | Discontinued | 2019-10-31 | 2019-11-01 | 97581 |
| ACT NABILONE | 0.5MG | CAPSULE | Discontinued | 2021-09-23 | 2021-09-23 | 146066 |
| ACT NABILONE | 0.5MG | CAPSULE | Discontinued | 2020-10-15 | 2020-10-15 | 126452 |
| ACT OLANZAPINE ODT | 15MG | TABLET (ORALLY DISINTEGRATING) | Discontinued | 2020-01-24 | 2020-01-24 | 104277 |
| ACT OLANZAPINE ODT | 5MG | TABLET (ORALLY DISINTEGRATING) | Discontinued | 2019-10-25 | 2019-10-26 | 97256 |
| ACT OLMESARTAN | 40MG | TABLET | Discontinued | 2020-06-11 | 2020-06-11 | 117500 |